JVMCX
Price
$24.96
Change
+$0.08 (+0.32%)
Updated
May 9 closing price
Net Assets
20.89B
OVEIX
Price
$10.22
Change
-$0.01 (-0.10%)
Updated
May 9 closing price
Net Assets
25.47M
Ad is loading...

JVMCX vs OVEIX

Header iconJVMCX vs OVEIX Comparison
Open Charts JVMCX vs OVEIXBanner chart's image
JHancock Disciplined Value Mid Cap C
Price$24.96
Change+$0.08 (+0.32%)
VolumeN/A
Net Assets20.89B
Sterling Capital Mid Value I
Price$10.22
Change-$0.01 (-0.10%)
VolumeN/A
Net Assets25.47M
JVMCX vs OVEIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVMCX vs. OVEIX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMCX is a Buy and OVEIX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 20.9B vs. OVEIX (25.5M). OVEIX pays higher dividends than JVMCX: OVEIX (0.55) vs JVMCX (0.00). JVMCX was incepted earlier than OVEIX: JVMCX (14 years) vs OVEIX (29 years). JVMCX (1.88) is less costly to investors than OVEIX (0.91). JVMCX is a more actively managed with annual turnover of: 47.00 vs. OVEIX (19.99). JVMCX has a lower initial minimum investment than OVEIX: JVMCX (1000) vs OVEIX (1000000). JVMCX annual gain was more profitable for investors over the last year : -9.46 vs. OVEIX (-36.20). JVMCX return over 5 years is better than : 47.59 vs. OVEIX (-18.22).
JVMCXOVEIXJVMCX / OVEIX
Total Expense Ratio1.870.91205%
Annual Report Gross Expense Ratio1.880.91207%
Fund Existence14 years29 years-
Gain YTD-1.660-31.2235%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets20.9B25.5M81,961%
Annual Yield % from dividends0.000.55-
Returns for 1 year-9.46-36.2026%
Returns for 3 years3.55-42.74-8%
Returns for 5 years47.59-18.22-261%
Returns for 10 years21.62-47.29-46%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
THISX75.26N/A
N/A
T. Rowe Price Health Sciences I
WFGGX27.82N/A
N/A
First Trust WCM Focused Global Gr Inv
TWVLX7.72N/A
N/A
American Century Value Inv
IJMAX14.83N/A
N/A
VY® JPMorgan Mid Cap Value A
RPXIX26.85N/A
N/A
RiverPark Large Growth Institutional